Clinical use of 11C-methionine and 18F-FDG-PET for germinoma in central nervous system

Annals of Nuclear Medicine

Volumn 28, Issue 2, 2014, Pages 94-102

  Okochi, Yoshiyuki ^a   Nihashi, Takashi ^a   Fujii, Masazumi ^a   Kato, Katsuhiko ^a   Okada, Yumiko ^a   Ando, Yoshio ^b   Maesawa, Satoshi ^c   Takebayashi, Shigenori ^d   Wakabayashi, Toshihiko ^a   Naganawa, Shinji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^c Dept of Surgery   (Japan)

^d NAGOYA CENTRAL HOSPITAL   (Japan)

Author keywords

11C methionine; 18F FDG; Germinoma; Positron emission tomography

Indexed keywords

CARBOPLATIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; METHIONINE C 11;

ADOLESCENT; ADULT; ARTICLE; BASAL GANGLION; BRAIN RADIATION; BRAIN REGION; CENTRAL NERVOUS SYSTEM GERMINOMA; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; GERM CELL TUMOR; GRAY MATTER; HISTOPATHOLOGY; HUMAN; MALE; PET SCANNER; PINEAL BODY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; SUPRASELLAR REGION; WHITE MATTER;

ADOLESCENT; ADULT; BRAIN; CARBON RADIOISOTOPES; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; GERMINOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; NERVE FIBERS, MYELINATED; NERVE FIBERS, UNMYELINATED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84896707532     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-013-0787-4     Document Type: Article

References (26)

1. States. TCBTRotU. Primary brain and central nervous system tumors diagnosed in the United States in 2004-2007. CBTRUS Statistical Report 2011. 2011: Available at: http://www.cbtrus.org/.
2. Japan TBTRo. Incidence of primary tumors. Neurol Med Chirur (Tokyo). 1992;32:395.
3. Kaur H, Singh D, Peereboom DM. Primary central nervous system germ cell tumors. Curr Treat Options Oncol. 2003;4(6):491-8.
4. Health NCIatNIo. Childhood central nervous system germ cell tumors treatment. 2012: Available at: http://www.cancer.gov/.
5. Kobayashi T, Yoshida J, Ishiyama J, Noda S, Kito A, Kida Y. Combination chemotherapy with cisplatin and etoposide for malignant intracranial germ-cell tumors. An experimental and clinical study. J Neurosurg. 1989;70(5):676-81. doi: 10.3171/jns.1989.70.5.0676.
6. Sawamura Y, Ikeda J, Shirato H, Tada M, Abe H. Germ cell tumours of the central nervous system: treatment consideration based on 111 cases and their long-term clinical outcomes. Eur J Cancer. 1998;34(1):104-10.
7. Yoshida J, Sugita K, Kobayashi T, Takakura K, Shitara N, Matsutani M, et al. Prognosis of intracranial germ cell tumours: effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16). Acta Neurochir. 1993;120(3-4):111-7.
8. Matsutani M, Japanese Pediatric Brain Tumor Study G. Combined chemotherapy and radiation therapy for CNS germ cell tumors-the Japanese experience. J Neurooncol. 2001;54(3):311-6.
9. Fujii Y, Saito Y, Ogawa T, Fujii S, Kamitani H, Kondo S, et al. Basal ganglia germinoma: diagnostic value of MR spectroscopy and (11)C-methionine positron emission tomography. J Neurol Sci. 2008;270(1-2):189-93. doi: 10.1016/j.jns.2008.02.006.
10. Kamoshima Y, Sawamura Y. Update on current standard treatments in central nervous system germ cell tumors. Curr Opin Neurol. 2010;23(6):571-5. doi: 10.1097/WCO.0b013e32833ff522.
11. Kawai N, Miyake K, Nishiyama Y, Yamamoto Y, Miki A, Haba R, et al. Targeting optimal biopsy location in basal ganglia germinoma using C-11-methionine positron emission tomography. Surg Neurol. 2008;70(4):408-13. doi: 10.1016/j.surneu.2007.04.010.
12. Kawai N, Miyake K, Yamamoto Y, Nishiyama Y, Maeda Y, Kageji T, et al. Use of (11)C-methionine positron emission tomography in basal germinoma: assessment of treatment response and residual tumor. Child Nerv Syst. 2009;25(7):845-53. doi: 10.1007/s00381-009-0841-7.
13. Kim CH, Paek SH, Park IA, Chi JG, Kim DG. Cerebral germinoma with hemiatrophy of the brain: report of three cases. Acta Neurochir. 2002;144(2):145-50. doi: 10.1007/s007010200017 (discussion 50).
14. Kim DI, Yoon PH, Ryu YH, Jeon P, Hwang GJ. MRI of germinomas arising from the basal ganglia and thalamus. Neuroradiology. 1998;40(8):507-11.
15. Lee J, Lee BL, Yoo KH, Sung KW, Koo HH, Lee SJ, et al. Atypical basal ganglia germinoma presenting as cerebral hemiatrophy: diagnosis and follow-up with (11)C-methionine positron emission tomography. Child Nerv Syst. 2009;25(1):29-37. doi: 10.1007/s00381-008-0674-9.
16. Sudo A, Shiga T, Okajima M, Takano K, Terae S, Sawamura Y, et al. High uptake on 11C-methionine positron emission tomographic scan of basal ganglia germinoma with cerebral hemiatrophy. AJNR Am J Neuroradiol. 2003;24(9):1909-11.
17. van Battum P, Huijberts MSP, Heijckmann AC, Wilmink JT, Krusernan ACN. Intracranial multiple midline germinomas: is histological verification crucial for therapy? Neth J Med. 2007;65(10):386-9.
18. Dhermain FG, Hau P, Lanfermann H, Jacobs AH, van den Bent MJ. Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas. Lancet Neurol. 2010;9(9):906-20. doi: 10.1016/S1474-4422(10)70181-2.
19. Hillner BE, Siegel BA, Shields AF, Duan F, Gareen IF, Hanna L, et al. Impact of dedicated brain PET on intended patient management in participants of the national oncologic PET registry. Mol Imaging Biol. 2011;13(1):161-5. doi: 10.1007/s11307-010-0427-5.
20. la Fougere C, Suchorska B, Bartenstein P, Kreth FW, Tonn JC. Molecular imaging of gliomas with PET: opportunities and limitations. Neuro Oncol. 2011;13(8):806-19. doi: 10.1093/neuonc/nor054.
21. Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med. 2006;354(5):496-507. doi: 10.1056/NEJMra050276.
22. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48(6):932-45. doi: 10.2967/jnumed.106.035774.
23. Sadamura Y, Sugiyama K, Uchida H, Hanaya R, Eguchi K, Kurisu K, et al. Intracranial germinoma presenting with hemiatrophy - follow-up results and literature review - two case reports. Neurol Med Chir. 2011;51(2):148-52.
24. Yu CH, Peller PJ, Subramaniam R. F-18 FDG PET/CT imaging of intraventricular germinoma. Clin Nucl Med. 2009;34(6):393-4. doi: 10.1097/RLU.0b013e3181a34540.
25. Utsuki S, Kawano N, Oka H, Tanaka T, Suwa T, Fujii K. Cerebral germinoma with syncytiotrophoblastic giant cells: feasibility of predicting prognosis using the serum hCG level. Acta Neurochir. 1999;141(9):975-7 (discussion 7-8).
26. Utsuki S, Oka H, Tanaka S, Tanizaki Y, Fujii K. Long-term outcome of intracranial germinoma with hCG elevation in cerebrospinal fluid but not in serum. Acta Neurochir. 2002;144(11):1151-4. doi: 10.1007/s00701-002-1008-4 (discussion 4-5).